Peptide Protocol

DSIP: delta sleep induction — sleep deeper, recover faster.

Delta Sleep-Inducing Peptide. Promotes slow-wave sleep and normalizes stress hormone rhythms. SubQ evening dosing.

Open Calculator 🌶️ All Protocols →
peppercalc.com · research use only
100–500 mcg
Per Dose
1–4 weeks
Cycle
SubQ
Route
Evening (pre-sleep)
Frequency
Overview

What is DSIP?

DSIP was discovered in 1977 by Monnier and colleagues who observed that dialysate from the thalamic region of sleeping rabbits could induce delta sleep in awake animals. The peptide sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu was subsequently synthesized and confirmed to retain sleep-promoting activity. It is found in the brain, pituitary, and peripheral tissues.

Beyond sleep induction, DSIP appears to regulate the hypothalamic-pituitary-adrenal (HPA) axis, reducing chronic cortisol elevation and normalizing disturbed circadian hormone rhythms. It has been studied for pain management, alcohol withdrawal, and stress-related disorders. Its broad neuroendocrine regulatory effects make it of interest for recovery optimization in research contexts.

💤
Delta Sleep Induction
Acts on central sleep-regulating circuits to promote slow-wave (delta) sleep — the most restorative sleep stage critical for GH release and tissue repair.
📉
HPA Axis Normalization
Modulates hypothalamic-pituitary-adrenal function, reducing chronically elevated cortisol and normalizing disturbed circadian ACTH rhythms.
🧠
Neuroendocrine Regulation
Influences release of multiple pituitary hormones including GH, LH, and TSH, with normalizing effects on dysregulated hormone patterns.
🛡️
Antistress Properties
Demonstrated antistress and potentially analgesic effects in animal models, reducing stress-induced corticosterone elevation.
Dosing Protocol

Dosing Schedule

Parameters documented in published preclinical and clinical research.

⚠️ Research use only. The following documents parameters from published preclinical and clinical research. Not medical advice. Not for human consumption. Consult a licensed healthcare professional before any use.
PhaseDoseFrequencyDurationNotes
Research100–200 mcgEvening SubQAs neededEvening Subcutaneous administration 30–60 min before intended sleep.
Working dose200–500 mcgEvening SubQShort coursesHigher doses may be needed for pronounced sleep disruption research.
IV protocol25 mcg/kgIV slow infusionClinical studiesIV delivery used in original clinical sleep research protocols.
Cycling5 days on / 2 offEvening3–4 weeksCycle to assess sustained effects on sleep architecture.
Safety Profile

Safety & Side Effects

✓ Generally Well Tolerated
Endogenous peptide — naturally present in human brain and periphery
Promotes restorative slow-wave sleep without benzodiazepine mechanism
Normalizes HPA axis function rather than suppressing it
Generally well tolerated in published studies
⚠ Potential Concerns
Limited modern clinical trial data — most research from 1970s–90s
Variable individual response — some report minimal sleep effect
Short plasma half-life — IV preferred in formal studies
Long-term effects on sleep regulation not well established
⚠️
Research use onlyThis page is an educational reference. None of this constitutes medical advice. Consult a qualified professional before any use. All compounds are for research purposes only.
Evidence Base

Academic References

  1. [1]
    Monnier M, et al. (1977). The delta sleep-inducing peptide (DSIP). Experientia. 33(4):548–52. PubMed ↗
  2. [2]
    Schneider-Helmert D. (1984). DSIP in insomnia. Eur Neurol. 23(5):358–63. PubMed ↗
  3. [3]
    Khvatova EM, et al. (2003). Delta sleep inducing peptide (DSIP): effect on respiration activity in mitochondria. Peptides. 24(2):307–11. PubMed ↗
  4. [4]
    Graf MV, Kastin AJ. (1986). Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev. 10(3):303–45. PubMed ↗
Recommended Source
Source your compounds at White Market Peptides
Use code PEPPERCALC10 for 10% off + free 2-day shipping over $200
Shop Now →